The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Flu Vaccine Market Research Report 2025
Synopsis
The global market for Flu Vaccine was valued at US$ 8955 million in the year 2024 and is projected to reach a revised size of US$ 12990 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.
The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Flu Vaccine was valued at US$ 8955 million in the year 2024 and is projected to reach a revised size of US$ 12990 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.
The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Flu Vaccine Market Overview
1.1 Product Definition
1.2 Flu Vaccine by Type
1.2.1 Global Flu Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Flu Vaccine by Application
1.3.1 Global Flu Vaccine Market Value by Application (2024 VS 2031)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global Flu Vaccine Revenue 2020-2031
1.4.2 Global Flu Vaccine Sales 2020-2031
1.4.3 Global Flu Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Flu Vaccine Market Competition by Manufacturers
2.1 Global Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Flu Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Flu Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Flu Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Flu Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Flu Vaccine, Date of Enter into This Industry
2.8 Global Flu Vaccine Market Competitive Situation and Trends
2.8.1 Global Flu Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Flu Vaccine Players Market Share by Revenue
2.8.3 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Flu Vaccine Market Scenario by Region
3.1 Global Flu Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Flu Vaccine Sales by Region: 2020-2031
3.2.1 Global Flu Vaccine Sales by Region: 2020-2025
3.2.2 Global Flu Vaccine Sales by Region: 2026-2031
3.3 Global Flu Vaccine Revenue by Region: 2020-2031
3.3.1 Global Flu Vaccine Revenue by Region: 2020-2025
3.3.2 Global Flu Vaccine Revenue by Region: 2026-2031
3.4 North America Flu Vaccine Market Facts & Figures by Country
3.4.1 North America Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Flu Vaccine Sales by Country (2020-2031)
3.4.3 North America Flu Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Flu Vaccine Market Facts & Figures by Country
3.5.1 Europe Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Flu Vaccine Sales by Country (2020-2031)
3.5.3 Europe Flu Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Flu Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Flu Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Flu Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Flu Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Flu Vaccine Market Facts & Figures by Country
3.7.1 Latin America Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Flu Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Flu Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Flu Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Flu Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Flu Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Flu Vaccine Sales by Type (2020-2031)
4.1.1 Global Flu Vaccine Sales by Type (2020-2025)
4.1.2 Global Flu Vaccine Sales by Type (2026-2031)
4.1.3 Global Flu Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Flu Vaccine Revenue by Type (2020-2031)
4.2.1 Global Flu Vaccine Revenue by Type (2020-2025)
4.2.2 Global Flu Vaccine Revenue by Type (2026-2031)
4.2.3 Global Flu Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Flu Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Flu Vaccine Sales by Application (2020-2031)
5.1.1 Global Flu Vaccine Sales by Application (2020-2025)
5.1.2 Global Flu Vaccine Sales by Application (2026-2031)
5.1.3 Global Flu Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Flu Vaccine Revenue by Application (2020-2031)
5.2.1 Global Flu Vaccine Revenue by Application (2020-2025)
5.2.2 Global Flu Vaccine Revenue by Application (2026-2031)
5.2.3 Global Flu Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Flu Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Flu Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Flu Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Flu Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Flu Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Flu Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Company Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hualan Bio Flu Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.7.1 Changchun Institute of Biological Company Information
6.7.2 Changchun Institute of Biological Description and Business Overview
6.7.3 Changchun Institute of Biological Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changchun Institute of Biological Flu Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Company Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinovac Flu Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Company Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BCHT Flu Vaccine Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Company Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu GDK Flu Vaccine Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Company Information
6.11.2 KM Biologics Description and Business Overview
6.11.3 KM Biologics Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 KM Biologics Flu Vaccine Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Flu Vaccine Industry Chain Analysis
7.2 Flu Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Flu Vaccine Production Mode & Process Analysis
7.4 Flu Vaccine Sales and Marketing
7.4.1 Flu Vaccine Sales Channels
7.4.2 Flu Vaccine Distributors
7.5 Flu Vaccine Customer Analysis
8 Flu Vaccine Market Dynamics
8.1 Flu Vaccine Industry Trends
8.2 Flu Vaccine Market Drivers
8.3 Flu Vaccine Market Challenges
8.4 Flu Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Flu Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Flu Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Flu Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Flu Vaccine Sales (M Doses) of Key Manufacturers (2020-2025)
Table 5. Global Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Flu Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Flu Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Flu Vaccine Average Price (USD/Doses) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Flu Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Flu Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Flu Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Flu Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Flu Vaccine Sales by Region (2020-2025) & (M Doses)
Table 18. Global Flu Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Flu Vaccine Sales by Region (2026-2031) & (M Doses)
Table 20. Global Flu Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Flu Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Flu Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Flu Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Flu Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Flu Vaccine Sales by Country (2020-2025) & (M Doses)
Table 27. North America Flu Vaccine Sales by Country (2026-2031) & (M Doses)
Table 28. North America Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Flu Vaccine Sales by Country (2020-2025) & (M Doses)
Table 32. Europe Flu Vaccine Sales by Country (2026-2031) & (M Doses)
Table 33. Europe Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Flu Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Flu Vaccine Sales by Region (2020-2025) & (M Doses)
Table 37. Asia Pacific Flu Vaccine Sales by Region (2026-2031) & (M Doses)
Table 38. Asia Pacific Flu Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Flu Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Flu Vaccine Sales by Country (2020-2025) & (M Doses)
Table 42. Latin America Flu Vaccine Sales by Country (2026-2031) & (M Doses)
Table 43. Latin America Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Flu Vaccine Sales by Country (2020-2025) & (M Doses)
Table 47. Middle East and Africa Flu Vaccine Sales by Country (2026-2031) & (M Doses)
Table 48. Middle East and Africa Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Flu Vaccine Sales (M Doses) by Type (2020-2025)
Table 51. Global Flu Vaccine Sales (M Doses) by Type (2026-2031)
Table 52. Global Flu Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Flu Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Flu Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Flu Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Flu Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Flu Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Flu Vaccine Price (USD/Doses) by Type (2020-2025)
Table 59. Global Flu Vaccine Price (USD/Doses) by Type (2026-2031)
Table 60. Global Flu Vaccine Sales (M Doses) by Application (2020-2025)
Table 61. Global Flu Vaccine Sales (M Doses) by Application (2026-2031)
Table 62. Global Flu Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Flu Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Flu Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Flu Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Flu Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Flu Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Flu Vaccine Price (USD/Doses) by Application (2020-2025)
Table 69. Global Flu Vaccine Price (USD/Doses) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 73. Sanofi Flu Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. CSL Company Information
Table 76. CSL Description and Business Overview
Table 77. CSL Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 78. CSL Flu Vaccine Product
Table 79. CSL Recent Developments/Updates
Table 80. GSK Company Information
Table 81. GSK Description and Business Overview
Table 82. GSK Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 83. GSK Flu Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Viatris Company Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 88. Viatris Flu Vaccine Product
Table 89. Viatris Recent Developments/Updates
Table 90. AstraZeneca Company Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 93. AstraZeneca Flu Vaccine Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Hualan Bio Company Information
Table 96. Hualan Bio Description and Business Overview
Table 97. Hualan Bio Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 98. Hualan Bio Flu Vaccine Product
Table 99. Hualan Bio Recent Developments/Updates
Table 100. Changchun Institute of Biological Company Information
Table 101. Changchun Institute of Biological Description and Business Overview
Table 102. Changchun Institute of Biological Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 103. Changchun Institute of Biological Flu Vaccine Product
Table 104. Changchun Institute of Biological Recent Developments/Updates
Table 105. Sinovac Company Information
Table 106. Sinovac Description and Business Overview
Table 107. Sinovac Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 108. Sinovac Flu Vaccine Product
Table 109. Sinovac Recent Developments/Updates
Table 110. BCHT Company Information
Table 111. BCHT Description and Business Overview
Table 112. BCHT Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 113. BCHT Flu Vaccine Product
Table 114. BCHT Recent Developments/Updates
Table 115. Jiangsu GDK Company Information
Table 116. Jiangsu GDK Description and Business Overview
Table 117. Jiangsu GDK Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 118. Jiangsu GDK Flu Vaccine Product
Table 119. Jiangsu GDK Recent Developments/Updates
Table 120. KM Biologics Company Information
Table 121. KM Biologics Description and Business Overview
Table 122. KM Biologics Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 123. KM Biologics Flu Vaccine Product
Table 124. KM Biologics Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Flu Vaccine Distributors List
Table 128. Flu Vaccine Customers List
Table 129. Flu Vaccine Market Trends
Table 130. Flu Vaccine Market Drivers
Table 131. Flu Vaccine Market Challenges
Table 132. Flu Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Flu Vaccine
Figure 2. Global Flu Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Flu Vaccine Market Share by Type: 2024 & 2031
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Flu Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Flu Vaccine Market Share by Application: 2024 & 2031
Figure 8. 6 Months to 3 Years
Figure 9. > 3 Years
Figure 10. Global Flu Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Flu Vaccine Market Size (2020-2031) & (US$ Million)
Figure 12. Global Flu Vaccine Sales (2020-2031) & (M Doses)
Figure 13. Global Flu Vaccine Average Price (USD/Doses) & (2020-2031)
Figure 14. Flu Vaccine Report Years Considered
Figure 15. Flu Vaccine Sales Share by Manufacturers in 2024
Figure 16. Global Flu Vaccine Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Flu Vaccine Players: Market Share by Revenue in Flu Vaccine in 2024
Figure 18. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Flu Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Flu Vaccine Sales Market Share by Country (2020-2031)
Figure 21. North America Flu Vaccine Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Flu Vaccine Sales Market Share by Country (2020-2031)
Figure 25. Europe Flu Vaccine Revenue Market Share by Country (2020-2031)
Figure 26. Germany Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Flu Vaccine Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Flu Vaccine Revenue Market Share by Region (2020-2031)
Figure 33. China Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Flu Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Flu Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Flu Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Flu Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Flu Vaccine by Type (2020-2031)
Figure 53. Global Revenue Market Share of Flu Vaccine by Type (2020-2031)
Figure 54. Global Flu Vaccine Price (USD/Doses) by Type (2020-2031)
Figure 55. Global Sales Market Share of Flu Vaccine by Application (2020-2031)
Figure 56. Global Revenue Market Share of Flu Vaccine by Application (2020-2031)
Figure 57. Global Flu Vaccine Price (USD/Doses) by Application (2020-2031)
Figure 58. Flu Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
